ROSWELL PARK CANCER INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Phase 2
Completed
Conditions
First Posted Date
2003-01-28
Last Posted Date
2011-03-08
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00053131
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

First Posted Date
2003-01-28
Last Posted Date
2011-03-01
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
1
Registration Number
NCT00053118
Locations
🇺🇸

St. Louis Children's Hospital, Saint Louis, Missouri, United States

🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

🇺🇸

University of Texas - MD Anderson Cancer Center, Houston, Texas, United States

Photodynamic Therapy in Treating Patients With Skin Cancer

First Posted Date
2003-01-27
Last Posted Date
2013-10-10
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
180
Registration Number
NCT00002975
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome

First Posted Date
2003-01-27
Last Posted Date
2013-01-31
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00030550
Locations
🇺🇸

PPD Development, Wilmington, North Carolina, United States

Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia

Not Applicable
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2013-01-31
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00022035
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Photodynamic Therapy in Treating Patients With Skin Cancer

Phase 2
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2013-01-31
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00002963
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Dimesna in Treating Patients With Solid Tumors Who Are Undergoing Treatment With Cisplatin and Paclitaxel

First Posted Date
2003-01-27
Last Posted Date
2013-01-31
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
2
Registration Number
NCT00003569
Locations
🇺🇸

University of Chicago Cancer Research Center, Chicago, Illinois, United States

🇺🇸

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States

🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

S-3304 in Treating Patients With Advanced Solid Tumors

First Posted Date
2003-01-27
Last Posted Date
2011-03-07
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00033566
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Vaccine Therapy in Treating Patients With Non-Small Cell Lung Cancer

Phase 1
Completed
Conditions
First Posted Date
2003-01-27
Last Posted Date
2011-03-07
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00023985
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

© Copyright 2024. All Rights Reserved by MedPath